Epstein Secrets

e other EFTA00135850 half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses will be available when people

ers and cyber-sleuths face an equally pressing challenge in the potential security threats surrounding a product in such high demand." In addition, Richard Engel reported on NBC Nightly News (12/7, story 3, 1:40, Holt, 6.35M) that Interpol "worries the doses could be stolen or counterfeited for the black ma

527269-gottlieb-warns-that-long-term-effects-of-covid-still- unknown> (11/23, Weixel, 2.98M) reports former Food and Drug Administration commissioner Scott Gottlieb spoke Monday at a American Enterprise Institute panel discussion, where he warned that medical community does not have enough data to understand th

" On NBC Nightly News <https://playvideo.bulletinintelligence.com/7005eb3c5d8e48a88846f58d9863576d? pubid=fbi> (11/23, story 5, 0:50, Holt, 6.28M), Richard Engel said that Oxford and AstraZeneca "have a distribution plan. Two hundred million doses this year. Those three billion doses next year, of which 300 m

nd hold back the other half to give the same people their second dose of the two-shot regimen," but former FDA commissioner and Pfizer board member Scott Gottlieb "says that's a bad idea. Instead, Gottlieb says he would give out 35 million doses now, and presume the second doses will be available when people

cers and cyber-sleuths face an equally pressing challenge in the potential security threats surrounding a product in such high demand." In addition, Richard Engel reported on NBC Nightly NewsVi (12/7, story 3, 1:40, Holt, 6.35M) that Interpol "worries the doses could be stolen or counterfeited for the black m

." Gottlieb Issues Warning About Long-Term COVID Effects. The Hill (11/23, Weixel, 2.98M) reports former Food and Drug Administration commissioner Scott Gottlieb spoke Monday at a American Enterprise Institute panel discussion, where he warned that medical community does not have enough data to understand the

atures, making it potentially easier to distribute, especially in developing countries." On NBC Nightly NewsVi (11/23, story 5, 0:50, Holt, 6.28M), Richard Engel said that Oxford and AstraZeneca "have a distribution plan. Two hundred million doses this year. Those three billion doses next year, of which 300